[HTML][HTML] Association of Molnupiravir and Nirmatrelvir-Ritonavir with preventable mortality, hospital admissions and related avoidable healthcare system cost among …
Background Real-world data is currently limited on the association between oral antiviral
therapy and healthcare system burden in patients with mild-to-moderate COVID-19. This …
therapy and healthcare system burden in patients with mild-to-moderate COVID-19. This …
[引用][C] Association of Molnupiravir and Nirmatrelvir-Ritonavir with preventable mortality, hospital admissions and related avoidable healthcare system cost among high …
AKC Wai, CY Chan, AWL Cheung, K Wang… - The Lancet Regional …, 2023 - cir.nii.ac.jp
Association of Molnupiravir and Nirmatrelvir-Ritonavir with preventable mortality, hospital
admissions and related avoidable healthcare system cost among high-risk patients with mild to …
admissions and related avoidable healthcare system cost among high-risk patients with mild to …
Association of Molnupiravir and Nirmatrelvir-Ritonavir with preventable mortality, hospital admissions and related avoidable healthcare system cost among high-risk …
AKC Wai, CY Chan, AWL Cheung… - The Lancet …, 2023 - pubmed.ncbi.nlm.nih.gov
Background Real-world data is currently limited on the association between oral antiviral
therapy and healthcare system burden in patients with mild-to-moderate COVID-19. This …
therapy and healthcare system burden in patients with mild-to-moderate COVID-19. This …
Association of Molnupiravir and Nirmatrelvir-Ritonavir with preventable mortality, hospital admissions and related avoidable healthcare system cost among high-risk …
AK Wai, CY Chan, AW Cheung, K Wang… - The Lancet Regional …, 2022 - europepmc.org
Background Real-world data is currently limited on the association between oral antiviral
therapy and healthcare system burden in patients with mild-to-moderate COVID-19. This …
therapy and healthcare system burden in patients with mild-to-moderate COVID-19. This …
[引用][C] Association of Molnupiravir and Nirmatrelvir-Ritonavir with preventable mortality, hospital admissions and related avoidable healthcare system cost among high …
KCA Wai, CY Chan, AWL Cheung, K Wang… - The Lancet Regional …, 2022 - hub.hku.hk
HKU Scholars Hub: Association of Molnupiravir and Nirmatrelvir-Ritonavir with preventable
mortality, hospital admissions and related avoidable healthcare system cost among high-risk …
mortality, hospital admissions and related avoidable healthcare system cost among high-risk …
[HTML][HTML] Association of Molnupiravir and Nirmatrelvir-Ritonavir with preventable mortality, hospital admissions and related avoidable healthcare system cost among …
AKC Wai, CY Chan, AWL Cheung, K Wang… - The Lancet Regional …, 2023 - Elsevier
Background Real-world data is currently limited on the association between oral antiviral
therapy and healthcare system burden in patients with mild-to-moderate COVID-19. This …
therapy and healthcare system burden in patients with mild-to-moderate COVID-19. This …
[HTML][HTML] Association of Molnupiravir and Nirmatrelvir-Ritonavir with preventable mortality, hospital admissions and related avoidable healthcare system cost among …
AKC Wai, CY Chan, AWL Cheung, K Wang… - The Lancet Regional …, 2023 - ncbi.nlm.nih.gov
Background Real-world data is currently limited on the association between oral antiviral
therapy and healthcare system burden in patients with mild-to-moderate COVID-19. This …
therapy and healthcare system burden in patients with mild-to-moderate COVID-19. This …